Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.

Background: The lengthy and expensive process of developing a novel medicine often takes many years and entails a significant financial burden due to its poor success rate. Furthermore, the processing and analysis of quickly expanding massive data necessitate the use of cutting-edge methodologies. As a result, Artificial Intelligence-driven methods that have been shown to improve the efficiency and accuracy of drug discovery have grown in favor.